Dr. Braddock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
310 CEDAR STREET
BML-165
New Haven, CT 06510Phone+1 203-737-1278- Is this information wrong?
Summary
- I am a physician/scientist, at Yale, where I have led an independently funded laboratory and practiced hematopathology since 2004. My laboratory's focus is the study severe poorly addressed human disease with an emphasis on the elucidation of disease pathogenesis to unveil therapeutic targets. I am particularly interested in rare diseases of children, and in the design and engineering of novel biologics to modulate disease outcome.
Education & Training
- National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 1996 - 2000
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1996
- University of ChicagoPh.D., Biochemistry, 1994
- University of ChicagoA.B., Chemistry, 1988
Certifications & Licensure
- NY State Medical License 2012 - 2025
- TN State Medical License 2012 - 2024
- CT State Medical License 2004 - 2024
- CA State Medical License 2010 - 2023
- MD State Medical License 2012 - 2022
- NJ State Medical License 2012 - 2021
- GA State Medical License 2012 - 2020
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Hematopathology
- Join now to see all
Awards, Honors, & Recognition
- Commissioned Officer U.S. Public Health Service Home (USPHS)
- Dean's List University of Chicago
- Emerging Leaders' Program Yale New Haven Hospital (YNHH), Yale School of Management, 2014
- Join now to see all
Publications & Presentations
PubMed
- Hypophosphatemic rickets: An unexplained early feature of craniometaphyseal dysplasia.Julio Soto Barros, Demetrios Braddock, Thomas O Carpenter> ;Bone Reports. 2023 Dec 1
- 1 citationsENPP1 in Blood and Bone: Skeletal and Soft Tissue Diseases Induced by ENPP1 Deficiency.Carlos R Ferreira, Thomas O Carpenter, Demetrios T Braddock> ;Annual Review of Pathology. 2024 Jan 24
- Genetics of Diffuse Idiopathic Skeletal Hyperostosis and Ossification of the Spinal Ligaments.Hajime Kato, Demetrios T Braddock, Nobuaki Ito> ;Current Osteoporosis Reports. 2023 Oct 1
- Join now to see all
Journal Articles
- "In vivo correction of anaemia in Beta-thalassemic mice by gammaPNA-mediated gene editing with nanoparticle delivery"Bahal R, Ali McNeer N, Quijano E, Liu Y, Sulkowski P, Turchick A, Lu YC, Bhunia DC, Manna A, Greiner DL, Brehm MA, Cheng CJ, Lopez-Giraldez F, Ricciardi A, Beloor J, K..., Nature Communications, 1/26/2016
- "pHLIP® targeting of PNA to silence MicroRNA in tumors"Cheng, C.J., Bahal, R., Babar, I.A., Pincus, Z., Barrera, F., Liu, C., Svoronos, A., Braddock, D.T., Glazer, P.M., Engelman, D.M., Saltzman, W.M., Slack, F.J., Nature, 1/5/2015
- "ENPP1-Fc Fusion Protein Prevents Mortality and Vascular Calcifications in Rodent Model of Generalized Calcification of Infancy"Albright, R.A., Stabach, P., Cao, W., Kavanagh, D., Mullen, I., Braddock, A.A., Covo M.S., Tehan, M., Yang, G., Cheng, Z., Bouchard, K., Zhao-Xue, Y., Thorn, S., Wang,..., Nature Communications, 1/1/2015
- Join now to see all
Books/Book Chapters
Press Mentions
- Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business UpdatesAugust 15th, 2022
- Inozyme Pharma Reports First Quarter 2022 Financial Results and Provides Business HighlightsMay 10th, 2022
- Faculty Entrepreneurs Receive Research Support from Blavatnik Fund for Innovation at YaleMay 21st, 2021
- Join now to see all
Grant Support
- ENPP1 regulation of mammalian bone massNIH/NIAMS2022–2027
- Targeting NETs in Human DiseaseBlavatnik Foundation2021–2023
- Enzyme Therapy for CKD-MDB: Breaking the Barrier of Vascular CalcificationNIH/NIDDK2020–2023
- Discovery, Validation, and Translational Development of Biologic Therapeutics for Ectopic Calcification DisordersInozyme Pharma2017–2023
- Non – Nuclease Based Gene Editing for Hutchinson-Gilford ProgeriaNIH/NIAID2020–2022
- Structure-Function Studies On PUF60 &On Npp4National Center For Research Resources2011
- Locating The Regions Of An Adml 3'Intron RNA Analogue Bound To PUF60 RrmsNational Center For Research Resources2011
- Structure Of The Prometastatic Enzyme AutotaxinNational Center For Research Resources2010
- 3D Determination Of An Npase PhosphodiesteraseNational Center For Research Resources2008–2010
- Fir:Fuse ComplexNational Center For Research Resources2006
Hospital Affiliations
- Bridgeport HospitalBridgeport, Connecticut
- Yale-New Haven HospitalNew Haven, Connecticut
- Hospital of St RaphaelNew Haven, Connecticut
Industry Relationships
- Founder, SAB member, and Consultant, Inozyme Phama2017 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: